30.06.2017 | Clinical Study | Ausgabe 2/2017

Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma
- Zeitschrift:
- Journal of Neuro-Oncology > Ausgabe 2/2017